BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Catabasis Pharmaceuticals, Inc. To Present At 32nd Annual J.P. Morgan Healthcare Conference


1/8/2014 7:13:46 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

CAMBRIDGE, Mass., Jan. 8, 2014 /PRNewswire/ -- Catabasis Pharmaceuticals Inc. today announced that Jill Milne, Ph.D., Catabasis' co-founder and chief executive officer, will present an update on Catabasis at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Dr. Milne's presentation is scheduled for 9:30 a.m. PST on Thursday, January 16, 2014 in the Elizabethan C/D Ballroom of the Westin St. Francis Hotel.

About Catabasis

Catabasis is a clinical-stage company dedicated to the discovery and development of innovative medicines to treat inflammatory and metabolic diseases. The company's drug development programs are rooted in the principles of pathway pharmacology, the treatment of diseases by simultaneously modulating more than one target in a disease pathway. Using its proprietary SMART Linker technology, the company conjugates two drugs that act on different components of a disease pathway with the goal of producing new chemical entities with significantly enhanced efficacy and improved safety and tolerability profiles. The company has assembled a team of passionate and experienced scientists who are committed to improving the lives of patients. The company was founded in 2008 and is headquartered in Cambridge, Mass.

Please visit www.catabasis.com for more information.

Media Contacts

Corporate Contact

Tony Russo, Ph.D.

Amy Lynch

Matt Middleman, M.D.

Catabasis Pharmaceuticals Inc.

Russo Partners

T: (617)-349-1971

T: 212-845-4251

alynch@catabasis.com

T: 212-845-4272


tony.russo@russopartnersllc.com


matt.middleman@russopartnersllc.com


SOURCE Catabasis Pharmaceuticals Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES